MedPath

Determining the accuracy of non-invasive biomarkers for detecting pre-cancerous colorectal neoplasia

Not Applicable
Recruiting
Conditions
Bowel Cancer Surveillance
Colorectal Cancer
Inflammatory Bowel Disease
Pre-cancerous colorectal neoplasia
Cancer - Bowel - Back passage (rectum) or large bowel (colon)
Public Health - Health service research
Oral and Gastrointestinal - Inflammatory bowel disease
Registration Number
ACTRN12620000668909
Lead Sponsor
Flinders University of South Australia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
3000
Inclusion Criteria

People booked for a colonoscopy at our approved study sites who are:
- Aged 18 years or over, and
- Experiencing gastrointestinal symptoms such as: abdominal pain, a change in bowel habit, weight loss, rectal bleeding (inclusive of microscopic rectal bleeding such as a positive faecal occult blood test), iron deficiency/anaemia, and/or gastrointestinal inflammation, OR living with inflammatory bowel disease, and
- Willing and able to provide a blood, stool, and/or tissue sample

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath